These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16951234)

  • 21. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
    Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
    PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of mammaglobin as a novel serum marker for breast cancer.
    Bernstein JL; Godbold JH; Raptis G; Watson MA; Levinson B; Aaronson SA; Fleming TP
    Clin Cancer Res; 2005 Sep; 11(18):6528-35. PubMed ID: 16166429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas.
    Normanno N; Kim N; Wen D; Smith K; Harris AL; Plowman G; Colletta G; Ciardiello F; Salomon DS
    Breast Cancer Res Treat; 1995 Sep; 35(3):293-7. PubMed ID: 7579500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
    Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
    Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.
    Xu Y; Yao L; Li H; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Larsson O; Xie Y
    Breast Cancer Res Treat; 2006 May; 97(1):49-55. PubMed ID: 16319978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.
    De Luca A; Arra C; D'Antonio A; Casamassimi A; Losito S; Ferraro P; Ciardiello F; Salomon DS; Normanno N
    Oncogene; 2000 Nov; 19(51):5863-71. PubMed ID: 11127817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.
    Spiller CM; Gillis AJ; Burnet G; Stoop H; Koopman P; Bowles J; Looijenga LH
    Mol Oncol; 2016 Apr; 10(4):526-37. PubMed ID: 26654129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression.
    Sgambato A; Migaldi M; Montanari M; Camerini A; Brancaccio A; Rossi G; Cangiano R; Losasso C; Capelli G; Trentini GP; Cittadini A
    Am J Pathol; 2003 Mar; 162(3):849-60. PubMed ID: 12598319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
    De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
    Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma.
    Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS
    Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Cripto-1 in human milk.
    Bianco C; Wechselberger C; Ebert A; Khan NI; Sun Y; Salomon DS
    Breast Cancer Res Treat; 2001 Mar; 66(1):1-7. PubMed ID: 11368405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
    Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
    J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A; Kumar RS; Kumar NS
    J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
    Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
    Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.